The RSA Group, a leading life sciences executive search firm, is pleased to announce the appointment of Sylvie Pancheri as Head of Drug Safety & Pharmacovigilance at Cybin – a biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics. Sylvie started her new position on 12th June 2024.

Sylvie is trained as a medical doctor and has extensive experience in global safety for big pharmaceutical and biotechnology companies. She is highly knowledgeable in clinical development programmes for neurological indications and has hands-on experience with writing and reviewing safety documents.

In her new role as Head of Drug Safety & Pharmacovigilance, Sylvie will lead the establishment and maintenance of a pharmacovigilance system for Cybin, including the development of standard operating procedures and seamless pharmacovigilance processes. Sylvie will also collaborate with key stakeholders on risk assessments, management strategies and safety analyses.

Ollie Stephens, the RSA senior researcher who led and delivered this search, commented: “Sylvie’s impressive track record in drug safety and pharmacovigilance, combined with her enthusiasm about the future of psychedelic therapeutics, made her the ideal candidate for this position. I wish her every success in her new role.”


For further information, contact:
Ollie Stephens
Senior Researcher, The RSA Group

Notes to Editors

About The RSA Group
Founded in 1981, we are the pre-eminent global executive search firm in Life Sciences and Healthcare. We provide a unique combination of Executive Search and Executive Interims from Director to Board Level. In addition to supporting clients with market due diligence, competitor benchmarking, and brand perception surveys, we also review organisations as part of our People & Organisation Advisory and recommend the best options for evolution across organisational design, talent acquisition, development, and succession planning. With offices globally, we offer clients and candidates alike our in-depth knowledge and understanding of the life sciences industry, as well as first class project execution. To learn more about The RSA Group, visit

Share this: